
Arihant Capital Analyst Review 2027: Profit Up 60% as Broking Revenue Recovers
Updated: 20 Nov 2026 • 9:50 am
Posted by:

Arihant Capital Markets Stock Snapshot (19 Nov 2026)
- Current Market Price (CMP): ₹93.08
- 52-Week High / Low: ₹108.57 / ₹56.97
- Market Capitalisation: ₹1,020 crore
- P/E Ratio vs Industry P/E: 21.2 vs 34.2
- Latest Quarter (Q2 FY27) Revenue: ₹76.13 crore
- Latest Quarter (Q2 FY27) Net Profit: ₹20.90 crore
Quick Answer: The Arihant Capital analyst review 2027 finds no named brokerage coverage as of November 2026. Q2 FY27 revenue rose 32.9% to ₹76.13 crore and net profit rose 59.8% to ₹20.9 crore, taking first-half profit to ₹42.39 crore, well above the full FY26 profit of ₹31.5 crore. The stock closed at ₹93.08 on 19 November 2026, about 21 times trailing earnings, so any Arihant Capital share price target 2027 view depends on how long strong market activity lasts.
The Arihant Capital analyst review 2027 covers Arihant Capital Markets, an Indore-based financial services firm that offers stock broking, depository services, wealth management and investment banking to retail and institutional clients. Readers searching for an Arihant Capital share price target 2027 will not find a named brokerage figure, so results and valuation guide this review.
Arihant Capital Markets closed at ₹93.08 on 19 November 2026, about 14% below its 52-week high of ₹108.57 and about 63% above its low of ₹56.97. This Arihant Capital analyst review 2027 explains the profit rebound and what shapes the Arihant Capital stock outlook 2027.
Click Here – Get Free Investment Predictions
What Analysts Say in the Arihant Capital Analyst Review 2027
| Brokerage | Rating | Target Price | Date |
|---|---|---|---|
| No verified coverage | Not available | Not available | As of November 2026 |
No named brokerage covers Arihant Capital. Rival brokerages rarely publish research on each other, and with promoters holding about 68% and institutions almost nothing, the stock gets little outside attention.
The company's own quarterly numbers are the main reference point. This Arihant Capital analyst review 2027 therefore looks at how earnings have moved across market cycles.
Q2 FY27 Results in the Arihant Capital Analyst Review 2027
| Metric | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | ₹76.13 crore | ₹57.30 crore | Up 32.9% |
| EBITDA | ₹36.23 crore | ₹24.13 crore | Up 50.1% |
| Net profit | ₹20.90 crore | ₹13.08 crore | Up 59.8% |
| Q1 FY27 net profit | ₹21.49 crore | Not applicable | Similar level |
| H1 FY27 net profit | ₹42.39 crore | Not compared | Above FY26 total |
Revenue and net profit held close to June quarter levels, showing that the recovery is not a one-quarter spike. EBITDA margin was about 48%, reflecting how quickly profits rise for a broker once revenue covers fixed costs.
The rebound follows a weak second half of FY26, when profit fell to ₹5.18 crore in the December quarter and just ₹0.50 crore in the March quarter. In this Arihant Capital analyst review 2027, that swing shows how closely earnings follow market activity.
How Arihant Capital Makes Money
Arihant earns fees and interest from helping clients trade and invest in financial markets.
- Broking: commissions on equity, derivatives, currency and commodity trades.
- Interest income: earnings on client margin funding and deposits held with exchanges.
- Depository services: fees for holding clients' shares in demat form.
- Investment banking and wealth: fees from issue management, advisory and distribution of financial products.
FY26 revenue fell to ₹206.4 crore from ₹248 crore, and net profit fell to ₹31.5 crore from ₹58.7 crore, after ₹70.5 crore in FY24. Those numbers frame this Arihant Capital analyst review 2027, because the first half of FY27 has already beaten all of FY26.
Broking earnings rise and fall with trading volumes, market sentiment and new account openings. SEBI's tighter rules on equity derivatives since late 2024 cut retail options activity and hurt many brokers' income in FY26. The recovery in FY27 suggests activity has picked up, though it remains sensitive to regulation and market mood.
Operating cash flow was negative at about minus ₹122 crore in FY26, which is common for brokers when client funding and exchange margins rise, since that money is counted as an operating outflow. Investors tracking the Nifty Financial Services space often treat smaller brokers as a higher-beta way to play market activity.
One useful way to read the business is by its swings. In FY24, when markets were buoyant, the company earned ₹70.5 crore; in FY26, when derivatives activity cooled, profit fell to ₹31.5 crore. The first half of FY27 suggests a return towards the stronger end of that range, but the history shows that a single weak quarter can quickly erase gains, as the ₹0.50 crore March 2026 quarter did.
Growth Triggers in the Arihant Capital Analyst Review 2027
- Profit rebound: Q2 profit up 59.8% to ₹20.9 crore.
- Steady quarters: about ₹21 crore of profit in each of Q1 and Q2.
- High operating margin: EBITDA margin near 48%.
- Market activity: a recovery in trading volumes.
- Lower valuation: about 21 times earnings, central to any Arihant Capital share price target 2027 view.
Key Risks in the Arihant Capital Analyst Review 2027
- Market dependence: profit fell to ₹0.50 crore in the March 2026 quarter.
- Regulation: SEBI derivatives rules can cut trading volumes.
- Competition: discount brokers offer very low fees.
- Funding risk: client margin lending carries credit risk.
- Low coverage: no named research, a key point in the Arihant Capital analyst review 2027.
Compare Arihant Capital With Other Broking Stocks on the Univest Screener
Arihant Capital Analyst Review 2027: Stock at a Glance
| Metric | Value |
|---|---|
| Share Price (19 Nov 2026) | ₹93.08 |
| 52-Week High / Low | ₹108.57 / ₹56.97 |
| Market Capitalisation | About ₹1,020 crore |
| P/E (TTM) | About 21.2 |
| Industry P/E | About 34.2 |
| Price to Book | About 2.11 |
| Book Value per Share | ₹44.10 |
| Debt to Equity | 0.56 |
| FY26 Revenue / Net Profit | ₹206.4 crore / ₹31.5 crore |
The P/E of about 21 is below the industry level of about 34, and the stock trades near two times book value. In this Arihant Capital analyst review 2027, the trailing multiple would fall further if the first-half profit run rate continues.
Shareholding Trend
| Holder | Dec 2025 | Sep 2026 | Change |
|---|---|---|---|
| Promoters | 67.67% | 67.67% | No change |
| Foreign Investors (FII) | 0.05% | 0.10% | Up 0.05 points |
| Domestic Institutions (DII) | 0.01% | 0.02% | Flat |
| Public | 32.27% | 32.20% | Flat |
Ashok Kumar Jain holds 30.59% and Kiran Jain 18.38%, and the promoter stake did not change. Institutional ownership is almost nil, which the Arihant Capital analyst review 2027 links to the lack of research coverage.
What to Watch After the Arihant Capital Analyst Review 2027
- Trading volumes: whether market activity stays strong.
- Quarterly profit: holding near ₹20 crore.
- Regulation: any new SEBI rules on derivatives or margin.
- Client growth: new accounts and assets under advice.
- Coverage: any research that sets an Arihant Capital share price target 2027.
Final Word on the Arihant Capital Analyst Review 2027
The Arihant Capital analyst review 2027 shows a sharp profit recovery, steady quarters and a valuation below its industry, balanced against heavy dependence on market activity and regulation. The weak second half of FY26 shows how quickly earnings can fall.
The Arihant Capital stock outlook 2027 depends on trading volumes and regulation. Univest does not give a buy or sell call.
Disclaimer: This article is for educational and informational purposes only and is not investment advice or a recommendation to buy, sell or hold any security. Brokerage ratings and target prices quoted here are opinions of third-party research houses; Univest does not endorse them and gives no buy or sell call. Investments in the securities market are subject to market risks. Read all related documents carefully before investing. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.
Frequently Asked Questions
What does the Arihant Capital analyst review 2027 show?
It shows a strong profit recovery. Q2 FY27 revenue rose 32.9% to ₹76.13 crore and net profit rose 59.8% to ₹20.9 crore. First-half profit of ₹42.39 crore is above the full FY26 profit of ₹31.5 crore.
Is there an Arihant Capital share price target 2027 from brokerages?
No named brokerage target exists as of November 2026. The stock closed at ₹93.08 on 19 November 2026, about 14% below its 52-week high of ₹108.57. Results and valuation are the main reference points.
What does Arihant Capital Markets do?
Arihant Capital is an Indore-based firm offering stock broking, depository services, wealth management and investment banking. It earns commissions, interest and fees. Its clients include retail and institutional investors.
Why did Arihant Capital's profit fall in FY26?
Trading activity slowed after SEBI tightened rules on equity derivatives, which hurt broker revenues. Profit fell to ₹5.18 crore in the December 2025 quarter and ₹0.50 crore in the March 2026 quarter. FY26 profit dropped to ₹31.5 crore from ₹58.7 crore.
Is Arihant Capital stock undervalued based on the Arihant Capital analyst review 2027?
The stock trades at about 21 times earnings, below the industry P/E of about 34. Price to book is about 2.11. Earnings are volatile, which explains part of the discount.
What risks does the Arihant Capital analyst review 2027 highlight?
The main risks are dependence on market activity, SEBI regulation and competition from discount brokers. Client margin lending carries credit risk. There is no named research coverage.
What should investors track after the Arihant Capital analyst review 2027?
Track trading volumes and whether quarterly profit stays near ₹20 crore. Watch for new SEBI rules on derivatives or margin. Client and account growth also matter.
Recent Articles

Asian Paints Analyst Review 2027: Revenue Up 17% but Margins Slip, Brokers Cluster Near ₹2,600
20 November 2026

Arvind Analyst Review 2027: Record Quarter as Advanced Materials and Dalco-GFT Lift Revenue 23%
20 November 2026

Ashoka Metcast Analyst Review 2027: Profit Rests on Other Income as Steel Sales Stay Small
20 November 2026

Ashima Analyst Review 2027: Sales Jump but a ₹20 Crore Loss Clouds the Turnaround Story
20 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Asian Paints Analyst Review 2027: Revenue Up 17% but Margins Slip, Brokers Cluster Near ₹2,600
Arvind Analyst Review 2027: Record Quarter as Advanced Materials and Dalco-GFT Lift Revenue 23%
Ashoka Metcast Analyst Review 2027: Profit Rests on Other Income as Steel Sales Stay Small
Ashima Analyst Review 2027: Sales Jump but a ₹20 Crore Loss Clouds the Turnaround Story
Automotive Stampings Analyst Review 2027: Sales Up 59% and Profit More Than Doubles
Popular this week
Asahi Songwon Analyst Review 2027: Profit Jumps Sevenfold as Pigment Sales Rise 66%

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





